CAS 886047-22-9

Formula: C19H24ClN5O3S

InChI: InChI=1S/C19H24ClN5O3S/c1-10-13-15(21)16(17(27)22-11-3-4-11)29-19(13)23-18(14(10)20)28-9-12(26)25-7-5-24(2)6-8-25/h11H,3-9,21H2,1-2H3,(H,22,27)

InChI key: TYTGOXSAAQWLPJ-UHFFFAOYSA-N

SMILES: CC1=C2C(=C(SC2=NC(=C1Cl)OCC(=O)N3CCN(CC3)C)C(=O)NC4CC4)N

3-Amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methyl-1-piperazinyl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide

CAS: 886047-22-9

Formula: C₁₉H₂₄ClN₅O₃S

Purity: %

Color and Shape: Solid

Molecular weight: 437.9436

Ref: IN-DA01DP0L

LY2119620

CAS: 886047-22-9

LY2119620

Formula: C₁₉H₂₄ClN₅O₃S

Purity: ≥98%

Molecular weight: 437.94

Ref: 54-BUP02993

3-Amino-5-Chloro-N-Cyclopropyl-4-Methyl-6-(2-(4-Methylpiperazin-1-Yl)-2-Oxoethoxy)Thieno[2,3-B]Pyridine-2-Carboxamide

CAS: 886047-22-9

3-Amino-5-Chloro-N-Cyclopropyl-4-Methyl-6-(2-(4-Methylpiperazin-1-Yl)-2-Oxoethoxy)Thieno[2,3-B]Pyridine-2-Carboxamide

Formula: C₁₉H₂₄ClN₅O₃S

Purity: 95+%

Molecular weight: 437.94

Ref: 54-OR1023965

LY2119620

CAS: 886047-22-9

LY2119620 is a specific, and allosteric agonist of human M2 and M4 muscarinic acetylcholine receptors.

Formula: C₁₉H₂₄ClN₅O₃S

Purity: 99.97%

Color and Shape: White Solid

Molecular weight: 437.94

Ref: TM-T6575

LY2119620

CAS: 886047-22-9

3-Amino-5-chloro-N-cyclopropyl-4-methyl-6-(2-(4-methylpiperazin-1-yl)-2-oxoethoxy)thieno[2,3-b]pyridine-2-carboxamide

Formula: C₁₉H₂₄ClN₅O₃S

Purity: 95+%

Molecular weight: 437.94

Ref: IN-DG389282

LY 2119620

Controlled Product

CAS: 886047-22-9

Formula: C₁₉H₂₄ClN₃O₃S

Color and Shape: Neat

Molecular weight: 726.898

Ref: TR-L486250

LY 2119620-d3

Controlled Product

CAS: 886047-22-9

Formula: C₁₉D₃H₂₁ClN₅O₃S

Color and Shape: Neat

Molecular weight: 440.962

Ref: TR-L486252

LY 2119620

CAS: 886047-22-9

LY 2119620 is a functional assays that is a high-affinity allosteric modulator of the acetylcholine receptor. It has been shown to increase the current in functional assays and block acetylcholine-induced bronchoconstriction in guinea pigs. LY 2119620 also has been shown to have metabolic effects, such as lowering cholesterol and triglyceride levels, and inhibiting oxidation by acting as a catalyst at low energy. The compound class of LY 2119620 contains nitrogen atoms and is part of the group of allosteric binding drugs that work by binding to adenosine receptors. To date, LY 2119620 has yet to be tested on multi-walled carbon nanotubes but it is expected that it will bind well because of its similar structure.

Formula: C₁₉H₂₄ClN₅O₃S

Purity: Min. 95%

Molecular weight: 437.94 g/mol

Ref: 3D-LKB04722